resources
Developing Skin PAMPA for Transdermal Patches
Poster
Preview - This content has been restricted to logged in users only.
Commercially available transdermal patches (3 nicotine, 2 fentanyl, 1 rivastigmine and 1 ketoprofen) are studied
Poster
In the present study commercially available transdermal patches (3 nicotine, 2 fentanyl, 1 rivastigmine and 1 ketoprofen) are studied. Data are compared to the declared permeation speed that is indicated by the manufacturers.
Application Notes
Conserving biorelevant enzymatic activity during in vitro subcutaneous drug testing
Webinar
Barriers and solutions for mimicking an in vivo extracellular environment with in vitro tools